LEU— AI Stock Forecast & Price Targets
Published 6/19/2026 · A free sample of K3vl4r’s AI-powered analysis.
Kronos price forecasts, scored fundamentals & technicals, and a multi-horizon plan.
View the live LEU price forecast →
Centrus Energy (LEU) sits at the intersection of a powerful HALEU/nuclear-renaissance narrative and a richly valued, volatile small-cap with deteriorating near-term cash flow. At $191 the stock trades at ~56x trailing and ~63x forward earnings with 22% short interest, after a violent round-trip from ~$380 to ~$145 and back — the Oklo HALEU LOI is a genuine catalyst, but execution risk, capex burn, and a still-stretched multiple argue for selective accumulation rather than chasing.
Stock is extended into Kronos resistance at ~$195.76 after a +16% week and the Oklo-news pop. Avoid chasing here. Tactical plan: wait for either a pullback to $170-$175 (prior breakout/support zone) to initiate, or a daily close above $200 on volume to add on strength. Invalidation for a long: daily close below $160 reopens the $145 low. Size small (1-2% portfolio) given 6.76% daily volatility and 22% short float — squeeze risk cuts both ways.
1-6 month thesis: Oklo LOI likely triggers follow-on HALEU contract announcements (utilities, DOE) and re-rates the narrative, but the stock must also absorb continued FCF burn (-$58M last quarter) and possibly another quarter of soft revenue. Base case range $170-$260 over 6 months; bull case $300+ if a second major HALEU offtake is announced; bear case $130-$145 on a risk-off tape or capex overrun. Catalysts: next earnings (May 05 already passed in data; next Q print), DOE HALEU program updates, additional SMR partnerships. Change-of-mind triggers: cash burn accelerating past $75M/qtr, loss of a HALEU contract, or sustained break below $145.
1-3 year terminal thesis: Centrus is one of very few Western enrichers with a path to commercial HALEU production, a strategic national-security asset positioned for SMR fuel demand (Oklo, X-energy, TerraPower). If HALEU deliveries scale on schedule (2029 per Oklo deal), revenue and margins should inflect materially from today's $452M sales base. Fair value at 8-10x mature sales of $1.0-1.5B suggests $400-600+ in a bull outcome. Biggest structural risks: (1) project execution and capex creep — enrichment plants chronically slip; (2) competitive response from URENCO/Orano if HALEU economics prove attractive; (3) political/policy reversal on domestic enrichment subsidies; (4) the 4738% 10-year run means much of the optionality may already be priced in.
Revenue is lumpy and trending the wrong way recently: Q1'26 revenue of $76.7M is roughly half of Q2'25's $154.5M, and TTM sales growth is -4.05%. Margin quality is similarly inconsistent — gross margin swung from 34.9% (Q2'25) to -5.7% (Q3'25) back to 41.1% (Q1'26), with operating margin near breakeven (1.0%) in the latest quarter. Cash flow has deteriorated sharply: operating cash flow went from +$52.8M (Q2'25) to -$35.1M (Q1'26), and FCF was -$58.3M last quarter as capex stepped up to $23.2M, consistent with HALEU build-out. The balance sheet, however, is genuinely strong after equity/debt issuance: cash of $1.87B vs total debt of $1.18B (net cash ~$690M), current ratio 5.63, working capital $1.89B — providing ample runway to fund the enrichment expansion. ROE is modest at 12.25% and ROIC only 3.11%, so capital efficiency is unproven at the new scale. Valuation is demanding: P/E 56.4x, fwd P/E 62.7x, P/S 7.4x, EV/EBITDA 64.7x, with EPS Q/Q -72% and 5Y forward EPS growth modeled at -21.8%. Net: fortress liquidity and a real strategic asset, but the fundamentals do not yet support the multiple — the market is paying for the HALEU option, not current earnings.
Across timeframes the picture is a sharp 2025 mania (weekly chart peak ~$380) followed by a >60% drawdown to ~$145 and a recovery rally back to ~$191, still 63% below the 52-week high of $464.25. The 1h chart shows a clean uptrend off the mid-June low (~$170) with price pushing into Kronos forecast resistance near $195.76 — short-term momentum is constructive (Perf Week +16.2%) but the stock is now extended into the forecast line. Daily/4h Kronos forecasts diverge: the 4h model projects continuation toward $344 (bull continuation), while the 1d model implies mean-reversion toward $187 with a wide band (~$140-$240) — directionally these conflict, and accuracy stats confirm low confidence beyond a few days (directional accuracy collapses to <30% past horizon 8, MAPE ~24%). Price sits below SMA50 (-10.1%) and well below SMA200 (-31.2%), so the longer trend is still broken; RSI 46.97 is neutral. Key levels: support $165/$145 (recent swing lows), resistance $195-$200 (forecast line + round number), then $230-$240 (Feb breakdown shelf). Near-term model probability is bearish (bullish_prob 0.20).
The signal is the June 18-19 Oklo–Centrus LOI: Centrus will supply domestically produced HALEU for up to five Aurora powerhouses at the 1.2 GW Ohio Clean Energy Campus, with deliveries beginning 2029. This is a tangible commercial validation of the Piketon facility, positions Centrus as the de facto domestic HALEU supplier to a leading SMR developer, and was rewarded with a 12.4% one-day pop on above-average volume. State/federal political backing in Ohio adds policy tailwind. The noise is the broader 'nuclear renaissance' chatter and Zacks-style momentum pieces — these amplify sentiment but don't change near-term economics, since HALEU revenue from this LOI is back-end loaded to 2029+. Macro headlines (Schwab prediction markets, BTC options, Israel/Hezbollah ceasefire) are not LEU-specific and shouldn't drive the thesis.
Get AI analysis on any stock
This is one of hundreds of Kronos AI reports — scored fundamentals & technicals, bull/base/bear price targets, a multi-horizon plan, and continuously-updated forecasts across the market. Create a free account to explore them all.
Create your free account →Already a member? Sign in · Join our Discord